Risk factor
Strong trading liquidity
Profitability factor
Very strong margins and returns
About
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases....
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of EW is 92 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sugg
Buy
Sell